Christopher Hunt, an officer of International Money Express, Inc., filed a Form 144 notice of proposed sale of 19,000 shares of common stock, with an approximate sale date of November 13, 2026, through Merrill Lynch.
Director Alexandra Kate Blankenship filed a Form 144 notice of proposed sale with the SEC on November 13, 2026, covering 4,000 shares of International Seaways, Inc. common stock to be sold on the NYSE.
Wise Group plc's Chief Financial Officer, Emmanuel Francois Jean-Claude Laurent Thomassin, filed a Form 144 notice of proposed sale of securities on November 13, 2026, covering 6,040 Class A ordinary shares acquired through a restricted stock unit vesting on October 15, 2026.
Donnelley Financial Solutions, Inc. officer Daniel Leib filed a Form 144 notice on November 13, 2026, disclosing a proposed sale of 50,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.
Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 13, 2026, proposing the sale of 10,000 shares of AdaptHealth common stock through Morgan Stanley Smith Barney LLC.
Actuate Therapeutics, Inc. filed a quarterly report on Form 10-Q with the SEC covering the period ended September 30, 2026, disclosing a significant decline in cash and a shift to stockholders' deficit.
Stemtech Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting continued operating losses and a widening accumulated deficit for the direct-sales nutritional supplement company.
The Dale B. Wolf Revocable Trust, associated with a director of Molina Healthcare, Inc., filed a Form 144 notice on November 13, 2026, disclosing a proposed sale of 1,600 shares of Molina Healthcare common stock on the New York Stock Exchange.
Digi Power X Inc. filed Definitive Additional Materials on November 13, 2026, supplementing its proxy statement to disclose a related-party lease agreement with DOGE Capital, LLC, a company controlled by its CEO, effective July 1, 2026.
Dyadic International, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, disclosing a going-concern warning and a shift to a stockholders' deficit position.